Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease

被引:33
|
作者
Kasahara, M [1 ]
Takada, Y [1 ]
Kozaki, K [1 ]
Uryuhara, K [1 ]
Ogura, Y [1 ]
Ogawa, K [1 ]
Fujimoto, Y [1 ]
Tanaka, K [1 ]
机构
[1] Kyoto Univ Hosp, Dept Transplant Surg, Sakyo Ku, Kyoto 6068507, Japan
关键词
auxiliary liver transplantation; living donor liver transplantation; noncirrhotic metabolic liver disease; ornithine transcarbamylase deficiency;
D O I
10.1016/j.jpedsurg.2004.03.079
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Auxilliary partial orthotopic liver transplantation (APOLT) was introduced initially as a tentative or permanent support for patients with potentially reversible fulminant hepatic failure and has extended its indication to congenital metabolic disorder of the liver that has otherwise normal functional integrity. Postoperative management of APOLT is complicated because of functional portal flow competition between the native and graft liver. The native portal vein diversion to the graft is sometimes indicated to prevent functional competition; however, it is still an open question whether this technique can be theoretically indicated for APOLT patients. The authors report a on patient with ornithine transcarbamylase deficiency who received APOLT from a living donor without native portal vein diversion. Because of functional portal vein competition between the native and graft liver, the patient had to have portal vein diversion, portal vein embolization, and finally native hepatectomy to induce the graft regeneration after APOLT. After the experience of the current case, primary portal vein diversion for APOLT with noncirrhotic metabolic liver disease patients to prevent functional portal flow competition is recommended. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1138 / 1141
页数:4
相关论文
共 50 条
  • [31] Living Donor Liver Transplantation to a Survivor of Liver Resection for Hepatocellular Carcinoma with Major Portal Vein Invasion
    Sadamori, Hiroshi
    Yagi, Takahito
    Shinoura, Susumu
    Umeda, Yuzo
    Yoshida, Ryuichi
    Sato, Daisuke
    Nobuoka, Daisuke
    Utsumi, Masashi
    Fujiwara, Toshiyoshi
    ACTA MEDICA OKAYAMA, 2013, 67 (02) : 117 - 121
  • [32] Vascular Stents in the Management of Portal Venous Complications in Living Donor Liver Transplantation
    Cheng, Y. -F.
    Ou, H. -Y.
    Tsang, L. L. -C.
    Yu, C. -Y.
    Huang, T. -L.
    Chen, T. -Y.
    Concejero, A.
    Wang, C. -C.
    Wang, S. -H.
    Lin, T. -S.
    Liu, Y. -W.
    Yang, C. -H.
    Yong, C. -C.
    Chiu, K. -W.
    Jawan, B.
    Eng, H. -L.
    Chen, C-L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1276 - 1283
  • [33] Outcomes of Living Donor Liver Transplantation for Patients with Preoperative Portal Vein Problems
    Wahab, Mohamed Abdel
    Shehta, Ahmed
    Elshoubary, Mohamed
    Salah, Tarek
    Fathy, Omar
    Sultan, Ahmed
    Elghawalby, Ahmed Nabieh
    Ali, Mahmoud
    Yassen, Amr Mohamed
    Elmorshedi, Mohamed
    Eldesoky, Mohamed
    Monier, Ahmed
    Said, Rami
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (12) : 2055 - 2063
  • [34] Outcomes of Living Donor Liver Transplantation for Patients with Preoperative Portal Vein Problems
    Mohamed Abdel Wahab
    Ahmed Shehta
    Mohamed Elshoubary
    Tarek Salah
    Omar Fathy
    Ahmed Sultan
    Ahmed Nabieh Elghawalby
    Mahmoud Ali
    Amr Mohamed Yassen
    Mohamed Elmorshedi
    Mohamed Eldesoky
    Ahmed Monier
    Rami Said
    Journal of Gastrointestinal Surgery, 2018, 22 : 2055 - 2063
  • [35] Clinical analysis of living donor liver transplantation in patients with portal vein thrombosis
    Kim, Say-June
    Kim, Dong-Goo
    Park, Jung-Hyun
    Moon, In-Sung
    Lee, Myung-Duk
    Kim, Ji-Il
    Yoon, Young-Chul
    Yoo, Young-Kyung
    CLINICAL TRANSPLANTATION, 2011, 25 (01) : 111 - 118
  • [36] Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis
    Kurata, Nobuhiko
    Ogura, Yasuhiro
    Ogiso, Satoshi
    Onishi, Yasuharu
    Kamei, Hideya
    Kodera, Yasuhiro
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (04) : 337 - 342
  • [37] Living donor liver transplantation for idiopathic portal hypertension with focal nodular hyperplasia
    Yoshiaki Tanji
    Kenei Furukawa
    Yosuke Igarashi
    Mitsuru Yanagaki
    Koichiro Haruki
    Yoshihiro Shirai
    Tomohiko Taniai
    Takeshi Gocho
    Norimitsu Okui
    Toru Ikegami
    Surgical Case Reports, 8
  • [38] Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis
    Nobuhiko Kurata
    Yasuhiro Ogura
    Satoshi Ogiso
    Yasuharu Onishi
    Hideya Kamei
    Yasuhiro Kodera
    Hepatobiliary & Pancreatic Diseases International, 2019, 18 (04) : 337 - 342
  • [39] Hepatitis B vaccination after living donor liver transplantation
    Soejima, Yuji
    Ikegami, Toru
    Taketomi, Akinobu
    Yoshizumi, Tomoharu
    Uchiyama, Hideaki
    Harada, Noboru
    Yamashita, Yoichi
    Maehara, Yoshihiko
    LIVER INTERNATIONAL, 2007, 27 (07) : 977 - 982
  • [40] Sequential pancreaticoduodenectomy after living donor liver transplantation for cholagiocacinoma
    Soejima, Y.
    Ueda, S.
    Sanefuji, K.
    Kayashima, H.
    Yoshizumi, T.
    Ikegami, T.
    Yamashita, Y.
    Sugimachi, K.
    Iguchi, T.
    Taketomi, A.
    Maehara, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (10) : 2158 - 2162